TWD 28.85
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 115.48 Million TWD | 47.62% |
2022 | 78.23 Million TWD | -31.46% |
2021 | 114.14 Million TWD | -35.06% |
2020 | 175.75 Million TWD | 114.07% |
2019 | 82.1 Million TWD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 36.35 Million TWD | 6.07% |
2024 Q2 | 34.76 Million TWD | -4.37% |
2023 Q1 | 19.72 Million TWD | 80.38% |
2023 Q3 | 34.27 Million TWD | 73.73% |
2023 FY | - TWD | 47.62% |
2023 Q4 | 34.27 Million TWD | 0.0% |
2023 Q2 | 19.72 Million TWD | 0.0% |
2022 Q3 | 10.93 Million TWD | 0.0% |
2022 FY | - TWD | -31.46% |
2022 Q4 | 10.93 Million TWD | 0.0% |
2021 FY | - TWD | -35.06% |
2020 FY | - TWD | 114.07% |
2019 FY | - TWD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
St.Shine Optical Co.,Ltd. | 1.01 Billion TWD | 88.578% |
Bioteque Corporation | 736.13 Million TWD | 84.313% |
Chi Sheng Pharma & Biotech Co., Ltd | 117.55 Million TWD | 1.763% |
Sunder Biomedical Tech. Co., Ltd. | 76.61 Million TWD | -50.732% |
BenQ Medical Technology Corporation | 532.15 Million TWD | 78.299% |
Pacific Hospital Supply Co., Ltd | 673.8 Million TWD | 82.861% |
Unicon Optical Co., Ltd. | 377.24 Million TWD | 69.389% |
Formosa Optical Technology Co.,Ltd. | 1.04 Billion TWD | 88.954% |
Medeon Biodesign, Inc. | -1.14 Billion TWD | 110.113% |
Concord Medical Co., Ltd. | 137.47 Million TWD | 15.999% |
Crystalvue Medical Corporation | 149.73 Million TWD | 22.875% |
ICARES Medicus, Inc. | 165.54 Million TWD | 30.241% |
Lagis Enterprise Co., Ltd. | 112.36 Million TWD | -2.773% |
Amed Co., Ltd. | 157.32 Million TWD | 26.598% |